Earnings Insights
AI-generated analysis of quarterly earnings, concall highlights, and financial performance across Indian listed companies.
How to use these insights
Each article is built from earnings call transcripts and structured rank signals. Start with the latest summary, then open the stock page for the full company view, the concall page for quarter-by-quarter commentary, and the rankings dashboard to compare peers.
Vinati Organics Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
Overall growth supported by strategic capex (~INR360 crores in FY26), innovation, and operational efficiencies. Key concall takeaways from Vinati Organics's Q4…
26 Aug 2026
TD Power Systems Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
Clear path to INR 1,900-2,000 crores revenue in FY '27 driven by new products and export railway business. Key concall takeaways from TD Power Systems Ltd's Q4…
26 Aug 2026
Apollo Hospitals Enterprise Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
. Key concall takeaways from Apollo Hospitals Enterprise Ltd's Q4 FY25 earnings call — and how it ranks against sector peers.
26 Aug 2026
National Securities Depository Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
The contribution of subsidiaries to consolidated profits increased from 5% to 10%, indicating rising diversification benefits. Key concall takeaways from…
26 Aug 2026
Dreamfolks Servi Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
Revenue growth drivers include domestic air travel and credit card volumes, which grew 7.5% to 8% in FY '25. Key concall takeaways from Dreamfolks Servi's Q4…
26 Aug 2026
Olatech Solutions Q4 FY25: Order Book ₹35 Cr | Arthneeti
Q4 FY25
Current order book in hand: ₹35 crores (as of June 2025). Key concall takeaways from Olatech Solutions Ltd's Q4 FY25 earnings call — and how it ranks against…
26 Aug 2026
Shalby Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
Implant business is in high-growth mode: 4x growth in Indonesia, 35-40% growth in U.S., and 2.5x growth in India reported last year. Key concall takeaways from…
26 Aug 2026
FSN E-Commerce Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
Nykaa’s overall GMV grew 27% YoY in Q4 and 25% for the full year FY25, with net revenue growth at 24% YoY for the full year. Key concall takeaways from FSN…
26 Aug 2026
Vinyas Innovativ Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
600 to 750 crores. Key concall takeaways from Vinyas Innovativ's Q4 FY25 earnings call — and how it ranks against sector peers.
26 Aug 2026
Suraksha Diagnostic Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
Volume of tests conducted has been growing at around 10% year-on-year between FY '24 and FY '25. Key concall takeaways from Suraksha Diagnostic Ltd's Q4 FY25…
26 Aug 2026
Entero Healthcar Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
500 crores. Key concall takeaways from Entero Healthcar's Q4 FY25 earnings call — and how it ranks against sector peers.
26 Aug 2026
Esconet Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
Previous fundraising through preferential allotments (approximately 33 crores last year and 32.69 crores recently) has strengthened financials. Key concall…
26 Aug 2026
Narayana Hrudaya Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
Capex is split between regular maintenance/replacement (~INR 300 crores) and new greenfield/brownfield capacity (~INR 450 crores) with some variability based…
26 Aug 2026
Madhusudan Masa Q4 FY25 earnings call: Revenue & Margins | Arthneeti
Q4 FY25
There is mention of acquiring Vitagreen (completed with INR7.75 crore acquisition cost), which supports product and distribution expansion but not directly…
26 Aug 2026
UltraTech Cem. Q1 FY26 earnings call: Revenue & Margins | Arthneeti
Q1 FY26
The company is on track with its capex plan of INR 1,800 crores for this segment. Key concall takeaways from UltraTech Cem.'s Q1 FY26 earnings call — and how…
26 Aug 2026
Arkade Q1 FY26 earnings call: Revenue & Margins | Arthneeti
Q1 FY26
Sales volumes are growing steadily with good buyer interest, reflected by a 27% growth in area sold (48,000 sq ft) and 17% growth in pre-sales. Key concall…
26 Aug 2026
Nexus Select Trust Q1 FY26 earnings call: Revenue & Margins | Arthneeti
Q1 FY26
Like-for-like consumption growth showed sequential improvement, with 4.6% growth this quarter and 11% year-on-year including acquisitions, indicating positive…
26 Aug 2026
Leela Palaces Hotels Q1 FY26 earnings call: Revenue & Margins | Arthneeti
Q1 FY26
Digital investments and revenue management practices support sustained high double-digit RevPAR growth (~20% in Q1 FY26). Key concall takeaways from Leela…
26 Aug 2026
Aditya AMC Q1 FY26 earnings call: Revenue & Margins | Arthneeti
Q1 FY26
Encouragement of SIPs contributing 45% to total AUM, promoting asset stickiness and stable inflows. Key concall takeaways from Aditya AMC's Q1 FY26 earnings…
26 Aug 2026
Sheela Foam Q1 FY26 earnings call: Revenue & Margins | Arthneeti
Q1 FY26
100 crores by year-end, indicating strong growth potential, especially in rural markets (Page 22, Page 8). Key concall takeaways from Sheela Foam's Q1 FY26…
26 Aug 2026